Allergy and Immunology Natural History Study
Columbia University · NCT05584488
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 10000
- US sites recruiting
- 1
- Study start
- July 16, 2010
- Record last updated
- February 4, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This protocol is a natural history study designed to evaluate subjects (and some family members) with suspected or identified genetic diseases of allergic inflammation or Immune Dysregulation. Patients determined by clinical history and outside evaluations to be of interest will be consented and enrolled into this study. Blood specimens, stored blood products and derivatives, saliva, hair, fingernail clippings, cord blood, umbilical cord, bone marrow, tissue biopsies and/or buccal swabs from such patients and/or their family members will be obtained for research studies related to understanding genetic and immunopathogenic bases of these diseases. Outside medical records may be obtained, and patient evaluations may be performed to correlate to research laboratory testing results.
Conditions: Immune Deficiency; Immune Dysregulation Disorder; Allergic Inflammation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Subjects, ages birth to 99 years old, known to have or suspected of having an inherited disorder of allergic inflammation, or mast cell homeostasis, or activation or immune dysregulation.
- Blood relatives of enrolled subjects will be eligible for enrollment.
- There will be no discrimination as to age, gender, race, or disability.
- Subjects/guardians must be willing and able to give informed consent.
- Subjects must agree to have their blood stored for future studies of the immune system and/or other medical conditions.
Exclusion Criteria
- The presence of an acquired abnormality of the immune system, such as cytotoxic chemotherapy or malignancy may be grounds for possible exclusion if, in the opinion of the investigator, the presence of such a disease process would interfere with evaluation.
Recruiting US locations
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
New York, NY 10032
Site contact: Yannett Franklin · 212-305-0473 · ym206@cumc.columbia.edu
Study contacts (from the official record)
- Joshua D. Milner, MD · 212-305-2100 · jdm2249@cumc.columbia
- Yannett Franklin · 212-305-0473 · ym206@cumc.columbia.edu
Similar studies in New York
All dermatology studies in New York →- RecruitingHealthy volunteersPhase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Bambusa Therapeutics
- Location
- New York, NY + 2 other US sites
- Eligibility basics
- Ages 18–72
- RecruitingHealthy volunteers
Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser
Lumenis Be Ltd.
- Location
- New York, NY
- Eligibility basics
- Ages 21–55
- RecruitingHealthy volunteers
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Pfizer
- Location
- New York, NY
- Eligibility basics
- Ages 0 mo+ · Women only
- RecruitingPhase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Oruka Therapeutics, Inc.
- Location
- New York, NY + 22 other US sites
- Eligibility basics
- Ages 18+